Literature DB >> 24115156

Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.

Heather E Moad1, Augen A Pioszak.   

Abstract

Calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) are related peptides that are potent vasodilators. The CGRP and AM receptors are heteromeric protein complexes comprised of a shared calcitonin receptor-like receptor (CLR) subunit and a variable receptor activity modifying protein (RAMP) subunit. RAMP1 enables CGRP binding whereas RAMP2 confers AM specificity. How RAMPs determine peptide selectivity is unclear and the receptor stoichiometries are a topic of debate with evidence for 1:1, 2:2, and 2:1 CLR:RAMP stoichiometries. Here, we describe bacterial production of recombinant tethered RAMP-CLR extracellular domain (ECD) fusion proteins and biochemical characterization of their peptide binding properties. Tethering the two ECDs ensures complex stability and enforces defined stoichiometry. The RAMP1-CLR ECD fusion purified as a monomer, whereas the RAMP2-CLR ECD fusion purified as a dimer. Both proteins selectively bound their respective peptides with affinities in the low micromolar range. Truncated CGRP(27-37) and AM(37-52) fragments were identified as the minimal ECD complex binding regions. The CGRP C-terminal amide group contributed to, but was not required for, ECD binding, whereas the AM C-terminal amide group was essential for ECD binding. Alanine-scan experiments identified CGRP residues T30, V32, and F37 and AM residues P43, K46, I47, and Y52 as critical for ECD binding. Our results identify CGRP and AM determinants for receptor ECD complex binding and suggest that the CGRP receptor functions as a 1:1 heterodimer. In contrast, the AM receptor may function as a 2:2 dimer of heterodimers, although our results cannot rule out 2:1 or 1:1 stoichiometries.
© 2013 The Protein Society.

Entities:  

Keywords:  calcitonin family peptide; class B G protein-coupled receptor; neuropeptide; vasodilator

Mesh:

Substances:

Year:  2013        PMID: 24115156      PMCID: PMC3843631          DOI: 10.1002/pro.2377

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.

Authors:  N Tilakaratne; G Christopoulos; E T Zumpe; S M Foord; P M Sexton
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

2.  Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Nobumasa Hino; Noboru Ohsawa; Ken-ichi Okuda; Kensaku Sakamoto; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2011-12-28       Impact factor: 6.725

3.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

Authors:  G Christopoulos; K J Perry; M Morfis; N Tilakaratne; Y Gao; N J Fraser; M J Main; S M Foord; P M Sexton
Journal:  Mol Pharmacol       Date:  1999-07       Impact factor: 4.436

4.  An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.

Authors:  R Muff; N Bühlmann; J A Fischer; W Born
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

5.  From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.

Authors:  B Rist; M Entzeroth; A G Beck-Sickinger
Journal:  J Med Chem       Date:  1998-01-01       Impact factor: 7.446

6.  [Tyr0]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle.

Authors:  S Chakder; S Rattan
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

Review 7.  Calcitonin gene-related peptide: an update on the biology.

Authors:  Ana Recober; Andrew F Russo
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

8.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

9.  Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide.

Authors:  Masaya Toda; Tatsunori Suzuki; Kanako Hosono; Izumi Hayashi; Shinichiro Hashiba; Yuichiro Onuma; Hideki Amano; Yukiko Kurihara; Hiroki Kurihara; Hirotsugu Okamoto; Sumio Hoka; Masataka Majima
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

Review 10.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468

View more
  17 in total

1.  N-Glycosylation of Asparagine 130 in the Extracellular Domain of the Human Calcitonin Receptor Significantly Increases Peptide Hormone Affinity.

Authors:  Sang-Min Lee; Jason M Booe; Joseph J Gingell; Virginie Sjoelund; Debbie L Hay; Augen A Pioszak
Journal:  Biochemistry       Date:  2017-06-26       Impact factor: 3.162

Review 2.  Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.

Authors:  Sang-Min Lee; Jason M Booe; Augen A Pioszak
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

Review 3.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

4.  Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Authors:  Sang-Min Lee; Debbie L Hay; Augen A Pioszak
Journal:  J Biol Chem       Date:  2016-02-19       Impact factor: 5.157

Review 5.  Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.

Authors:  G R Kolar; S M Grote; G L C Yosten
Journal:  J Intern Med       Date:  2016-06-16       Impact factor: 8.989

6.  Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors.

Authors:  Jason M Booe; Margaret L Warner; Augen A Pioszak
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-24

Review 7.  Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.

Authors:  Rebekah L Bower; Debbie L Hay
Journal:  Br J Pharmacol       Date:  2016-05-18       Impact factor: 8.739

8.  Biochemical characterization of G protein coupling to calcitonin gene-related peptide and adrenomedullin receptors using a native PAGE assay.

Authors:  Amanda M Roehrkasse; Margaret L Warner; Jason M Booe; Augen A Pioszak
Journal:  J Biol Chem       Date:  2020-06-02       Impact factor: 5.157

9.  Impaired Vasodilatory Responses of Omental Arteries to CGRP Family Peptides in Pregnancies Complicated by Fetal Growth Restriction.

Authors:  Madhu Chauhan; Ancizar Betancourt; Meena Balakrishnan; Uma Yallampalli; Yuanlin Dong; Karin Fox; Michael Belfort; Chandra Yallampalli
Journal:  J Clin Endocrinol Metab       Date:  2016-06-03       Impact factor: 5.958

Review 10.  RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.

Authors:  Augen A Pioszak; Debbie L Hay
Journal:  Adv Pharmacol       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.